Skip to main content
SupplierTrail

The Sanapac Co., Inc.

FEI 2510359 · 1152 Twin Stacks Dr, Dallas, Pennsylvania, 18612-8505, United States

1 warning letter on record

Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports

Get a dated evidence report for this supplierFree · for your supplier file · sample

Import alerts
0
Import refusals (5 years)
0
Warning letters
1
Last FDA action
2026-01-22
9 months ago

FDA record

  1. 2026-01-22
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  2. 2019-05-07
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  3. 2019-05-07
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Foodborne Biological Hazards
    FDA source
  4. 2017-03-24
    Warning letterFDA Warning Letter (CFSAN)
    FDA source
  5. 2016-12-06
    InspectionFDA inspection · Classification: Official Action Indicated (OAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  6. 2012-01-20
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Foodborne Biological Hazards
    FDA source
  7. 2012-01-20
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  8. 2005-01-12
    RecallRecall F-185-5 · Class 2 · The product is adulterated since it contains the new dietary ingredient, androstenedione, for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.
    Sanapac''s Vee 200 for Men. The product is sold in 90 cc and 120 cc bottles of 30 and 50 tablets. The product is shipped in cases containing 12 bottles.
    Source: FDA Enforcement Reports